[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338135-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-338135-en":122},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","ccl5-promotes-the-epithelial-mesenchymal-transition-of-circulating-tumor-cells-in-renal-cancer-abstract-research-open-access","CCL5 promotes the epithelial-mesenchymal transition of circulating tumor cells in renal cancer - Abstract - Research Open Access","","Study examines how C–C motif chemokine ligand 5 (CCL5) drives tumorigenicity in renal cancer cells and circulating tumor cells (CTCs). Using bioinformatics, in vivo and in vitro experiments, the work evaluates CTC prognostic value with Lasso regression and Kaplan–Meier analyses. Findings show CCL5 high expression in CTCs linked to poor renal cancer prognosis, promotes EMT via smad2/3, increases CTCs and lung metastasis in nude mice, and highlights mesenchymal CTCs for risk modeling and personalized treatment.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ccl5-promotes-the-epithelial-mesenchymal-transition-of-circulating-tumor-cells-in-renal-cancer-abstract-research-open-access/338135/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ccl5-promotes-the-epithelial-mesenchymal-transition-of-circulating-tumor-cells-in-renal-cancer-abstract-research-open-access/338135.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"Which EMT-typed CTCs carried the highest prognostic value?","Question",{"text":63,"@type":64},"Mesenchymal-type CTCs showed the highest prognostic value among EMT-typed CTCs, supporting the construction of a risk model.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},338135,1790979856,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,107,111,114,118],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":104,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":105,"slug":106},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},"Religion & Spirituality",20,"religion-spirituality",{"id":109,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":109,"slug":113},"World Cup","world-cup",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":115,"slug":117},10,"Lifestyle","lifestyle",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":89,"slug":121},19,"General","general",{"code":4,"msg":74,"data":123},{"doc_id":71,"user_id":124,"nickname":42,"user_avatar":125,"doc_module":4,"category_id":104,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Guan et al. Journal of Translational Medicine (2024) 22:817  \n[https://doi.org/10.1186/s12967-024-05297-2](https://doi.org/10.1186/s12967-024-05297-2)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nCCL5 promotes the epithelial-mesenchymal   transition of circulating tumor cells in renal cancer  \nYibing Guan1,2†, Xueyi Liu3†, Juanhua Tian1, Guang Yang4†, Fangshi Xu1, Ni Guo5, Lingyu Guo1, Ziyan Wan1, Zhixin Huang1, Mei Gao1 and Tie Chong1*  \nAbstract  \nBackground Circulating tumor cells (CTCs) are pivotal in tumor metastasis across cancers, yet their specific role in renal cancer remains unclear.  \nMethods This study investigated C–C motif chemokine ligand 5 (CCL5)’s tumorigenic impact on renal cancer cells and CTCs using bioinformatics, in vivo, and in vitro experiments. It also assessed renal cancer patients’ CTCs prognostic value through Lasso regression and Kaplan–Meier survival curves.  \nResults Bioinformatics analysis revealed differential genes focusing on cellular adhesion and migration  \nbetween CTCs and tumor cells. CCL5 exhibited high expression in various CTCs, correlating with poor prognosis in renal cancer. In 786-O-CTCs, CCL5 enhanced malignancy, while in renal cell carcinoma cell line CAKI-2 and 786-O, it promoted epithelial-mesenchymal transition (EMT) via smad2/3, influencing cellular characteristics. The nude mouse model suggested CCL5 increased CTCs and intensified EMT, enhancing lung metastasis. Clinical results shown varying prognostic values for different EMT-typed CTCs, with mesenchymal CTCs having the highest value.  \nConclusions In summary, CCL5 promoted EMT in renal cancer cells and CTCs through smad2/3, enhancing the malignant phenotype and facilitating lung metastasis. Mesenchymal-type CTC-related factors can construct a risk model for renal cancer patients, allowing personalized treatment based on metastatic risk prediction.  \nKeywords CCL5, CTCs, Renal cancer, EMT, Prognosis  \n†Yibing Guan, Xueyi Liu and Guang Yang have contributed equally to this article.  \n*Correspondence: Tie Chong [chongtie@126.com](chongtie@126.com)  \n1 Department of Urology, School of Medicine, The Second Affiliated Hospital, Xi’an Jiaotong University, No 157 Xiwu Road, Xi’an 710004, Shaan Xi, China  \n2 Department of Urology, The First Affiliated Hospital, Zhengzhou University, No 1 Jianshe East Road, Zhengzhou 450052, He Nan, China  \n3 School of Chemistry, Xi’an Jiaotong University, Xi’an 710049, Shaanxi, China  \n4 Henan Key Lab Reprod & Genet, The First Affiliated Hospital, Zhengzhou University, No 1 Jianshe East Road, Zhengzhou 450052, He Nan, China  \n5 National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, No 157 Xiwu Road, Xi’an 710004, Shaan Xi, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativeco](http://creative","cbCaia2HBqYiWGKc","https://ap.wps.com/l/cbCaia2HBqYiWGKc","pdf",13034693,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Clinical challenge in renal cell carcinoma follow-up\n## Circulating tumor bodies and CTCs","[{\"question\":\"Which EMT-typed CTCs carried the highest prognostic value?\",\"answer\":\"Mesenchymal-type CTCs showed the highest prognostic value among EMT-typed CTCs, supporting the construction of a risk model.\"}]","CCL5 promotes the epithelial-mesenchymal transition of circulating tumor cells in renal cancer - Abstract - Research Open Access | PDF",1790022110,45,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62c4d23330468a5567c4223e7717f445.webp",983,1305,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13b3c3021eb836815cb40757d02c663d.webp",982,1304,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3dbf980ee0b823b71529228b2ba07af0.webp",981,1303,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d2eaecb373ff826e6adced397ffdae2.webp",980,1301]